Fig. 1.
2019 US market share distribution of hematopoietic growth factors. Data include pegfilgrastim (Neulasta®, FulphilaTM, Udenyca®), filgrastim (Neupogen®, Zarxio®, Granix®, Nivestym®), and sargramostim (Leukine®). Source: IQVIA National Sales Perspectives®, June 5, 2020.

2019 US market share distribution of hematopoietic growth factors. Data include pegfilgrastim (Neulasta®, FulphilaTM, Udenyca®), filgrastim (Neupogen®, Zarxio®, Granix®, Nivestym®), and sargramostim (Leukine®). Source: IQVIA National Sales Perspectives®, June 5, 2020.

Close Modal

or Create an Account

Close Modal
Close Modal